Expertise in
36
conditions

Dr. Fasahat H. Hamzavi

Dermatology
Hamzavi Pharmacy
2950 Keewahdin Rd, 
Fort Gratiot, MI 
Accepting New Patients
Referral may be required
Before you request
Expertise in
36
conditions
Hamzavi Pharmacy
2950 Keewahdin Rd, 
Fort Gratiot, MI 

Overview

Fasahat Hamzavi is a Dermatologist practicing medicine in Fort Gratiot, Michigan.

Dr. Hamzavi is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Universal Acquired Melanosis, Liver Spots, Actinic Keratosis, and Warts.

He is actively involved in clinical research, participating in 7 clinical trials. Dr. Hamzavi is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in MI

Hospital Affiliations

Mclaren Port Huron
Lake Huron Medical Center

Languages Spoken

English
Hindi
Urdu

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Hamzavi Pharmacy
2950 Keewahdin Rd, Fort Gratiot, MI 48059

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: April 07, 2026
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis
Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis
Enrollment Status: Completed
Publish Date: March 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE AD2) - A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE AD2) - A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Combination product
Study Phase: Phase 3
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Enrollment Status: Completed
Publish Date: June 04, 2019
Intervention Type: Other, Biological
Study Phase: Phase 2
A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
Enrollment Status: Completed
Publish Date: February 15, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials
Similar Doctors
Expertise in
31
conditions
Expertise in
31
conditions
Referral may be required

Hamzavi Dermatology

43151 Dalcoma Drive, Suite 4, 
Clinton Township, MI 
 (39.1 miles away)
586-286-8720
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients

Iltefat Hamzavi is a Dermatologist practicing medicine in Clinton Township, Michigan. Dr. Hamzavi is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Vitiligo, Hypomelanotic Disorder, Hidradenitis Suppurativa, and Pigmented Purpuric Dermatosis. Dr. Hamzavi is board certified in American Board Of Dermatology. Dr. Hamzavi is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required
Before you request

Henry Ford Medical Center-Farmington Road

6530 Farmington Rd, 
West Bloomfield, MI 
 (58.2 miles away)
248-661-8240
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Linda Stein-Gold is a Dermatologist practicing medicine in West Bloomfield, Michigan. Dr. Stein-Gold is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Acne, Rosacea, Plaque Psoriasis, and Psoriasis. Dr. Stein-Gold is currently accepting new patients.

Expertise in
93
conditions
Expertise in
93
conditions
Referral may be required
Before you request

Somerset Skin Centre

255 Kirts Boulevard, Suite 100, 
Troy, MI 
 (49.3 miles away)
248-244-8448
Languages Spoken:
English, Japanese
See accepted insurances
Accepting New Patients
Offers Telehealth

George Murakawa is a Dermatologist practicing medicine in Troy, Michigan. Dr. Murakawa is highly rated in 93 conditions, according to our data. His clinical expertise encompasses Neurocutaneous Melanosis, Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome. Dr. Murakawa is board certified in American Board Of Dermatology. Dr. Murakawa is currently accepting new patients.

Frequently Asked Questions about Dr. Fasahat H. Hamzavi

How do I make an appointment with Dr. Fasahat H. Hamzavi?

You can book an appointment with Dr. Fasahat H. Hamzavi by calling their office at 810-455-1600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Fasahat H. Hamzavi a top-rated expert for Universal Acquired Melanosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Fasahat H. Hamzavi is classified as an Distinguished expert for Universal Acquired Melanosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Fasahat H. Hamzavi specialize in?

While Dr. Fasahat H. Hamzavi is a Dermatology, they have specific expertise in Universal Acquired Melanosis, Liver Spots, and Actinic Keratosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Fasahat H. Hamzavi accept my insurance?

Dr. Fasahat H. Hamzavi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 810-455-1600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hamzavi's expertise for a condition
ConditionClose
    View All 32 Advanced Conditions
    View All 63 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile